Sunshine Biopharma
(NASDAQ) SBFM
Sunshine Biopharma Financials at a Glance
Market Cap
$2.41M
Revenue (TTM)
$35.49M
Net Income (TTM)
$6.04M
EPS (TTM)
$-1.30
P/E Ratio
-0.37
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$0.49
Volume
16,615,718.065
Open
$0.45
Price
$0.49
Volume
16,615,718.065
Open
$0.45
Previous Close
$0.48
Daily Range
$0.44 - $0.50
52-Week Range
$0.28 - $2.43
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$0.49
Volume
16,615,718.065
Open
$0.45
Previous Close
$0.48
Daily Range
$0.44 - $0.50
52-Week Range
$0.28 - $2.43
SBFM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sunshine Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
50
CEO
Steve N. Slilaty, PhD
Website
www.sunshinebiopharma.comHeadquarters
Pointe-Claire, QC H9R 0A5, CA
SBFM Financials
Key Financial Metrics (TTM)
Gross Margin
32%
Operating Margin
-13%
Net Income Margin
-17%
Return on Equity
-27%
Return on Capital
-21%
Return on Assets
-22%
Earnings Yield
-2.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.41M
Shares Outstanding
5.01M
Volume
16.62M
Avg. Volume
12.44M
Financials (TTM)
Gross Profit
$11.92M
Operating Income
$4.48M
EBITDA
$4.15M
Operating Cash Flow
$5.33M
Capital Expenditure
$174.49K
Free Cash Flow
$5.51M
Cash & ST Invst.
$9.12M
Total Debt
$812.42K
Sunshine Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.09M
-9.1%
Gross Profit
$2.10M
-22.9%
Gross Margin
26.01%
N/A
Market Cap
$2.41M
N/A
Market Cap/Employee
$46.33K
N/A
Employees
52
N/A
Net Income
$1.24M
-5.4%
EBITDA
$1.32M
-14.2%
Quarterly Fundamentals
Net Cash
$6.17M
-15.0%
Accounts Receivable
$4.01M
+16.4%
Inventory
$13.17M
+11.1%
Long Term Debt
$535.61K
-25.8%
Short Term Debt
$209.23K
-2.2%
Return on Assets
-21.62%
N/A
Return on Invested Capital
-20.76%
N/A
Free Cash Flow
$2.08M
-7.9%
Operating Cash Flow
$2.07M
-20.9%